EUVIMEDEUVIMED entdecken
Crossref

Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution

Ivan Civettini, Federica Malighetti, Matteo Villa, Valentina Crippa, Andrea Aroldi, Fabrizio Cavalca, Alex Graudenzi, Luca Lanino, Giulia Maggioni, Torsten Haferlach, Pierre Fenaux, Uwe Platzbecker und 17 weitere

NEJM Evidence · 26.05.2026 · 5 (6)

DOI: 10.1056/evidoa2500124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NEJM Evidence, erschienen am 26.05.2026. Verfasst von Ivan Civettini und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Evolution, Molecular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesEvolution, MolecularHumansProto-Oncogene MasPrognosisMutationCore Binding Factor Alpha 2 SubunitSerine-Arginine Splicing Factors

Substanzen

Proto-Oncogene MasMAS1 protein, humanCore Binding Factor Alpha 2 SubunitSRSF2 protein, humanSerine-Arginine Splicing FactorsRUNX1 protein, human

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Hematology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Experimental Immunology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Informatics, Systems and Communication, University of Milano-Bicocca, Milan, Italy.
  • Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Zitieren

APA

Civettini, I., Malighetti, F., Villa, M., Crippa, V., Aroldi, A., Cavalca, F., Graudenzi, A., Lanino, L., Maggioni, G., Haferlach, T., Fenaux, P., Platzbecker, U., Díez-Campelo, M., Borin, L. M., Fumagalli, M., Zappaterra, A., Manghisi, B., Al Ali, N. H., Sallman, D. A., …, & Ramazzotti, D. (2026). Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution. NEJM Evidence, 5(6). https://doi.org/10.1056/evidoa2500124

Vancouver

Civettini I, Malighetti F, Villa M, Crippa V, Aroldi A, Cavalca F, et al. Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution. NEJM Evidence. 2026;5(6). doi:10.1056/evidoa2500124

BibTeX
@article{Civettini2026,
  author = {Civettini, Ivan and Malighetti, Federica and Villa, Matteo and Crippa, Valentina and Aroldi, Andrea and Cavalca, Fabrizio and Graudenzi, Alex and Lanino, Luca and Maggioni, Giulia and Haferlach, Torsten and Fenaux, Pierre and Platzbecker, Uwe and Díez-Campelo, María and Borin, Lorenza Maria and Fumagalli, Monica and Zappaterra, Arianna and Manghisi, Beatrice and Al Ali, Najla H and Sallman, David A and Padron, Eric and Xie, Zhuoer and Chan, Onyee and Zeidan, Amer M and Mologni, Luca and Piazza, Rocco and Komrokji, Rami S and Della Porta, Matteo Giovanni and Gambacorti-Passerini, Carlo and Ramazzotti, Daniele},
  title = {Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution},
  journal = {NEJM Evidence},
  year = {2026},
  volume = {5},
  number = {6},
  doi = {10.1056/evidoa2500124}
}
Kostenlos starten →